Cardiovascular Diagnostics Market

Cardiovascular Diagnostics: Global Industry Analysis 2018-2022 and Opportunity Assessment 2023-2033

A recent market study published by FMI on Cardiovascular Diagnostics offers a global industry analysis for 2018-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

By Product:

• Electrocardiogram (ECG) system
• Resting ECG Systems
• Cardiopulmonary Stress Testing Systems
• Holter Monitoring Devices
• Event Monitoring Devices
• Implantable Loop Recorder (ILR)
• Others

By Point-of-Care Testing:

• Analyzers
• Lipoprotein Test Kits
• Angiotensin Test Kits
• Fibrinogen Test Kits
• Serum Uric Acid Test Kits
• High-Sensitivity CRP (hs-CRP) Kits

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Cardiac Catheterization Labs
• Diagnostic Imaging Centers

By Region:

• North America
• Latin America
• East Asia
• South Asia & Pacific
• Europe
• Central Asia
• Middle East and Africa

Report Chapters

Executive Summary

The executive summary of the Cardiovascular Diagnostics includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Cardiovascular Diagnostics.

Chapter 01 - Market Overview

Readers can find the detailed segmentation and definition of the Cardiovascular Diagnostics in this chapter, which will help to understand basic information about Cardiovascular Diagnostics. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Cardiovascular Diagnostics report.

Chapter 02 - Market Background

This chapter includes detailed analysis of the By Product processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.

Chapter 03 - Global Cardiovascular Diagnostics Demand Analysis 2018-2022 and Forecast, 2023-2033

The chapter include historical market value (USD 5.6 Billion) analysis (2018-2022) and current and future market value (USD 9.7 Billion) and volume (5.1%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.

Chapter 04 - Global Cardiovascular Diagnostics - Pricing Analysis

Based on By Product, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.

Chapter 05 - Global Cardiovascular Diagnostics Analysis 2018-2022 and Forecast 2023-2033, By Product

Based on By Product, Cardiovascular Diagnostics is segmented into Electrocardiogram (ECG) system, Resting ECG Systems, Cardiopulmonary Stress Testing Systems, Holter Monitoring Devices, Event Monitoring Devices, Implantable Loop Recorder (ILR), Others. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Product.

Chapter 06 - Global Cardiovascular Diagnostics Analysis 2018-2022 and Forecast 2023-2033, By Point-of-Care Testing

Based on By Point-of-Care Testing, Cardiovascular Diagnostics is segmented into Analyzers, Lipoprotein Test Kits, Angiotensin Test Kits, Fibrinogen Test Kits, Serum Uric Acid Test Kits, High-Sensitivity CRP (hs-CRP) Kits. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Point-of-Care Testing.

Chapter 07 - Global Cardiovascular Diagnostics Analysis 2018-2022 and Forecast 2023-2033, By End-Use

Based on By End-Use, Cardiovascular Diagnostics is segmented into Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Cardiac Catheterization Labs, Diagnostic Imaging Centers. This section also offers market attractiveness analysis based on By End-Use. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By End-Use.

Chapter 08 - Cardiovascular Diagnostics Analysis 2018-2022 and Forecast 2023-2033, By Region

Based on By Region, Cardiovascular Diagnostics is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.

Chapter 09 - North America Cardiovascular Diagnostics Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of the Cardiovascular Diagnostics in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.

Chapter 10 - Latin America Cardiovascular Diagnostics Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Cardiovascular Diagnostics in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Cardiovascular Diagnostics in the Latin America region.

Chapter 11 - Europe Cardiovascular Diagnostics Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Cardiovascular Diagnostics in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Cardiovascular Diagnostics in the regional market.

Chapter 12 - East Asia Cardiovascular Diagnostics Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Cardiovascular Diagnostics in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Cardiovascular Diagnostics in the regional market.

Chapter 13 - South Asia Cardiovascular Diagnostics Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Cardiovascular Diagnostics in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Cardiovascular Diagnostics in the regional market.

Chapter 14 - Middle East and Africa Cardiovascular Diagnostics Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Cardiovascular Diagnostics in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Cardiovascular Diagnostics in the regional market.

Chapter 15 - Key Countries Cardiovascular Diagnostics Analysis 2018-2022 and Forecast 2023-2033

This chapter offers insights into how the Cardiovascular Diagnostics is expected to grow in major countries globally.

Chapter 16 - Market Structure Analysis- Global Assessment

This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.

Chapter 17 - Competition Deep Dive (Tentative List)

This chapter includes company overview, By Product portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; Biotronik SE & Co. KG; Schiller, Koninklijke Philips N.V.; GE Healthcare and Wayra; Siemens Healthcare; Lepu Medical; Midmark Corp; Roche Ltd; Randox Laboratories Ltd.; Robonik India; Diasorin; Elabscience Biotechnology

Chapter 18 - Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Cardiovascular Diagnostics report.

Chapter 19 - Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Cardiovascular Diagnostics.